-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Upgrades BioLine Rx to Buy, Announces $12 Price Target

Benzinga·05/30/2025 13:17:39
Listen to the news
Jones Trading analyst Justin Walsh upgrades BioLine Rx (NASDAQ:BLRX) from Hold to Buy and announces $12 price target.